NASDAQ: KPTI Shareholder Alert: Lawsuit Alleges Misleading Statements by Karyopharm Therapeutics Inc.
An investor, who purchased shares of Karyopharm Therapeutics Inc. (NASDAQ: KPTI), filed a lawsuit against Karyopharm Therapeutics Inc over alleged violations of Federal Securities Laws.
View full press release